AVANT’s TP10 Complement Inhibitor Significantly Decreases Heart Attacks and Death in Men Following Cardiac Surgery
Results of Phase II Clinical Study of TP10 Presented at the American Heart Association Meeting in Orlando Use of an investigational therapeutic […]
